Clinical Trial Results:
            A double blind, double dummy, randomised, multicentre, two arm parallel group study to assess the efficacy and safety of FlutiForm® pMDI 125/5 µg (2 puffs bid) vs Symbicort® Turbohaler® 200/6 µg (2 puffs bid) in adolescent and adult subjects with moderate to severe persistent, reversible asthma.
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2009-017223-25 | 
    Trial protocol  | 
        PL HU BG | 
    Global completion date  | 
        
                                    30 Oct 2010
                             
         | 
    
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
| 
                 Results information 
         | 
        |
    Results version number  | 
        v3(current) | 
    This version publication date  | 
        
                                    06 Apr 2016
                             
         | 
    
    First version publication date  | 
        
                                    23 May 2015
                             
         | 
    
    Other versions  | 
        v1 , v2 | 
    Version creation reason  | 
        
  | 
    
    Summary report(s)  | 
                                FLT3507 synopsis | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.